Form 4/A for AIM AIM ImmunoTech Inc.
Accepted 2025-02-20 00:00:00 ET · period of report 2025-01-31 · accession 0001493152-25-007739 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| A | 2025-02-20 | 2025-01-31 | AIM | MITCHELL WILLIAM M | Dir | A - Grant | $0.2 | +25.8K | 198.1K | +15% | +$5,159 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-01-31 | A | A | 25,797 | $0.2 | 198,063 | D | — | — | (F2) This amended Form 4/A is filed to correct the D on the original filing to A. The shares were acquired, not disposed (F1) These shares are issued in lieu of director compensation pursuant to the issuer's Cash Conservation Plan. |